Cash Flow Alnylam Pharmaceuticals, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
323.00
-377.00
-433.00
-1,126.00
-852.00
-855.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-444.00
-214.00
10.00
-35.00
-162.00
-12.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
524.00
-8.00
104.00
-541.00
-641.00
-614.00
Cash Flow from Investing Activities
436.00
-116.00
-336.00
169.00
-273.00
-435.00
Cash Flow from Financing Activities
-305.00
294.00
172.00
425.00
1,247.00
994.00
Net Cash Inflow / Outflow
690.00
153.00
-53.00
46.00
323.00
-50.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
34.00
-15.00
6.00
-7.00
-9.00
4.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Alnylam Pharmaceuticals, Inc.
Figures in Million
consolidated Cash Flow Results
Change(USD)
Change(%)
Profit Before Tax
323.152
526.936
-203.00
-38.67%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-444.782
-11.98
-433.00
-3612.70%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
524.08
1257.842
-733.00
-58.33%
Cash Flow from Investing Activities
436.329
-134.001
570.00
425.62%
Cash Flow from Financing Activities
-305.19
-347.958
42.00
12.29%
Net Cash Inflow / Outflow
690.155
773.432
-83.00
-10.77%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
34.936
-2.451
36.00
1525.38%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
YoY Growth in year ended Dec 2025 is 6,405.10% vs -107.98% in Dec 2024
Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
524.08
-8.31
6,405.10%
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
